أفضل بودكاسات Iqvia (2024)

1
SFE Insights: Episode 2 | Predictive triggers: Optimizing patient care 12:32

22d ago12:32

12:32

Tune in to the latest episode of the IQVIA SFE Insights Podcast as Lakshdeep Singh, Senior Principal at IQVIA, and Goksu Dogan, Senior Principal in the Artificial Intelligence and Machine Learning Solutions team, explore the role of predictive analytics and real-time triggers in optimizing HCP engagement and improving patient outcomes. Discover how…

1
Clinical research in Egypt and Saudi Arabia 7:48

23d ago7:48

7:48

IQVIA Vice President for Clinical Operations Gjon Mirdita who oversees site management in the EMENA region shares his impressions on clinical operations from his recent visit to Egypt and Saudi Arabia, including the potential of clinical operations in these countries and the Middle East as a whole, IQVIA's work and cooperation with stakeholders in …

1
Launch Excellence: Episode 9 | US Edition Part II: The Rewrite of the Business of Launch 15:37

27d ago15:37

15:37

Elyse Munoz, IQVIA’s US Director of Research and Insights, joins the podcast to discuss insights from the second paper of a three-part series, all about optimizing a US launch. Expect to learn about what impacts the optimization phase of a US launch: patient adherence, market access in the US context (and how it’s different from Europe), and direct…

1
Lung Cancer in the Middle East 26:35

1M ago26:35

26:35

IQVIA's Vice President for Tech & Services in the Middle East, Rauf Mohamed spoke with Johnson & Johnson Managing Director for Innovative Medicine in the Gulf Region, Pedro Matos Rosa about lung cancer in the region. Pedro and Rauf discussed the severity of lung cancer and its prevalence throughout the region, key stats and insights, the progress i…

1
World Hepatitis Day: Eliminating Hepatitis C - Lessons from Egypt 17:44

2M ago17:44

17:44

In 2023, the WHO and the World Bank recognized Egypt's remarkable achievement in eradicating hepatitis C. This podcast features a special guest, H.E. Dr. Mohamed Hassany, Assistant to the Minister of Health for Public Health and Presidential Initiatives in Egypt, who shares the nation's journey from having one of the highest incidence rates of hepa…

1
Launch Excellence: Episode 8 | Patient Engagement and Support Services 14:57

2M ago14:57

14:57

In episode 8, IQVIA EMEA Thought Leaderships’ lead on patient engagement, Meike Madelung, joins the podcast to talk about why patient engagement and support services (PES) are important for launch. Hear examples of how PES can benefit patients, healthcare systems, and pharma companies striving for launch success.…

1
OneKey Reference Datasets: Episode 9 | Smith and Nephew Improved Operational Data Efficiency with OneKey’s Ecosystem 17:41

3M ago17:41

17:41

This podcast episode explores how data-driven solutions are transforming the healthcare industry. Our guest is Bob Forcier, a key figure at Smith and Nephew who plays a pivotal role in leveraging data for operational improvements. Bob shares insights on how Smith and Nephew define operational efficiency and the critical role OneKey data plays in ac…

1
Evolving with IQVIA: Agile Brand Promotion Episode 8 | Business Insights: Confronting Aspirations vs. The Realities of Your Omnichannel Engagement Strategy 24:31

3M ago24:31

24:31

Omnichannel is now a top priority for most pharma brand and commercial leaders. There’s a clear focus to embed omnichannel engagement and drive differentiating, consumer-like experiences within campaign plans and brand strategies. And while every organization is at a different maturity level, at IQVIA, we have seen a common trend that progress, reg…

1
OneKey Reference Datasets: Episode 8 | OneKey Data and MedTech Market Activator 14:07

3M ago14:07

14:07

In today’s complex healthcare landscape, understanding your customers is more challenging than ever, and as such, medical device and diagnostic line partners face significant gaps and unmet needs for their commercial teams. IQVIA’s latest solution, the MedTech Market Activator, fueled with OneKey data, empowers commercial teams with comprehensive i…

1
Patient Support Programs in Africa: Episode 2 | Case management, financial assistance, and the patient journey 9:06

4M ago9:06

9:06

In episode 2, we examine financial assistance or case management: What is a case management approach and the importance of looking at the whole patient journey.بقلم IQVIA

1
Patient Support Programs in Africa: Episode 1 | Patient Needs and Program Design 7:27

4M ago7:27

7:27

In this episode, we examine the needs of patients in the current health systems and the role and potential of patient support programs to improve patient access to reliable and innovative treatments.بقلم IQVIA

1
SFE Insights Series: Episode 1 | AIML Powered Referral Networks 8:47

4M ago8:47

8:47

Tune in as Paige Desmarais, IQVIA SFE Principal, and Ruoxin Li, IQVIA Sr Director in Advanced Analytics, delve into the transformative impact of AI and machine learning on healthcare analytics. In this episode, they explore how these technologies are reshaping provider referral patterns. As patient and provider journeys become increasingly complex,…

1
Clinical Trials Landscape in the UAE and Middle East: Opportunities, Challenges and Lessons Learned 23:56

4M ago23:56

23:56

Clinical trials play a significant role in the development of drugs and medical breakthroughs. They are key for the advancement of medicine, although not all stakeholders are aware of their strong impact on patient care. Listen to our podcast with guest speaker Dr. Nawal Al-Kaabi, Senior Advisor and Consultant, Pediatric Infectious Disease at Sheik…

1
MedTech Business Insights: Episode 10 | Advancing the Health Equity Journey in MedTech 18:04

5M ago18:04

18:04

In this episode, Dr. Shelly Nash, Senior Vice President and Global Chief Medical Information Officer at Fresenius Medical Care, discusses the importance of health equity and access to care in driving better health outcomes. Dr. Nash defines the issue of health equity and shares initiatives and opportunities for medical device and diagnostic compani…

1
Connected Care 13:14

5M ago13:14

13:14

IQVIA’s Vice President for Genomics and Precision Medicine Joanne Hackett discusses the importance of connected care, digital maturity, and innovation and technology in healthcare.بقلم IQVIA

1
The Expanded Program on Immunization 28:18

5M ago28:18

28:18

Learn about the progress and challenges facing the Expanded Program on Immunization in Nigeria.بقلم IQVIA

1
Launch Excellence: Episode 7 | Rare Disease Launch Excellence 18:40

5M ago18:40

18:40

In this episode, Sarah Rickwood and Stefan Lutzmayer discuss key findings from the “From Orphan to Opportunity: Mastering Rare Disease Launch Excellence” white paper. Discover how to navigate the complex rare disease landscape, overcome post-pandemic hurdles, and apply the three pillars of launch excellence to achieve success in rare diseases.…

1
AI for R&D: Episode 6 | Benefits of Patient Centricity in Design 11:54

6M ago11:54

11:54

This episode focuses on Patient Centricity in Design and how engaging patients in protocol design can improve clinical outcomes. IQVIA’s Patient Centricity in Design solution helps sponsors optimize study design for patient engagement and patient outcomes, such as incorporating diverse patient preferences, selecting design elements that align with …

1
MedTech Business Insights: Episode 9 | Top MedTech Trends in 2024 21:10

6M ago21:10

21:10

In this episode, IQVIA’s Raj Stewart and Michelle Edwards dig deeper into IQVIA’s annual “Ten MedTech Trends to Watch” report, which focuses on the key trends impacting the U.S. MedTech industry today. Learn how health equity, the consolidation of health systems, and advances in diagnostics are impacting the need for evidence generation among MedTe…

1
Launch Excellence: Episode 6 | US Edition: The Rewrite of the Business of Launch 14:11

6M ago14:11

14:11

Sarah Rickwood is joined by Elyse Muñoz, IQVIA’s US Director of Research & Insights, to discuss the first of a three-part launch excellence series on the current state of US launch and the new rules for launching excellently in the US, the most important market for global innovative medicines success.…

1
Consumer Health Edge: Episode 3 | Mastering Data: A Beginner’s Guide to Information Management 12:06

7M ago12:06

12:06

Dive into the world of data management with “Consumer Health Edge” podcast’s latest episode, “Mastering Data; A Beginner’s Guide to Information Management.” Join host Vaishnavi Save as she welcomes Antonello Moscatelli, a seasoned expert with nearly two decades of experience in Data and Analytics. Together, they explore the crucial steps organizati…

1
South Africa's National Health Insurance Program: Episode 4 | Dr. Larisse Prinsen 15:26

7M ago15:26

15:26

Dr. Larisse Prinsen provides an overview of challenges, changes required, and implications of the NHI, from a legal perspective.

1
Rare diseases in the Middle East: Part 2 of 2 | Challenges and Opportunities 10:17

7M ago10:17

10:17

Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the final part of our podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to t…

1
Rare diseases in the Middle East: Part 1 of 2 | Challenges and Opportunities 14:59

7M ago14:59

14:59

Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the first of our 2-part podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to…

1
South Africa's National Health Insurance Program: Episode 3 | Prof. Nicholas Crisp 24:58

7M ago24:58

24:58

Prof. Nicholas Crisp discusses South Africa's National Health Insurance, its potential, the reforms, changes, challenges, and the roles of the public and private sectors.

1
Consumer Health Edge: Episode 2 | Empowering Insights: The Next Step of Healthcare Sales 16:51

7M ago16:51

16:51

In Episode 2 of our Consumer Health Edge podcast, Vaishnavi Save and Ankit Gupta delve into the dynamic world of data-driven customer journeys, sales, and distribution. We uncover the pivotal role of data analytics in optimizing shelf space for consumer health companies, suggesting how tools revolutionize in-store strategies. Understanding the cons…

1
Personalization Science: Episode 3 | The Evolution of Media Optimization Part 2 23:03

8M ago23:03

23:03

Welcome back to IQVIA Digital Enablement’s podcast series: Personalization Science. This is part 2 of our conversation with Jason Patterson, Chief Analytics Officer at Publicis Health Media. This time, host Andrew Burkus, leads an insightful discussion on the future of measurement and optimization, the role AI may play in this evolution, and how al…

1
Cancer Care in Low- and Middle-Income Countries: Bridging the Gap 22:29

8M ago22:29

22:29

IQVIA invited Eric Grant, the Communications and Media Manager for the Union for International Cancer Control (UICC), to delve into the critical issue of the cancer care gap in low- and middle-income countries (LMICs) across the Middle East and Africa, shedding light on the challenges these countries encounter while striving to bridge this gap and …

1
South Africa's National Health Insurance Program: Episode 2 | Prof. Roseanne Harris 20:55

8M ago20:55

20:55

Prof. Roseanne Harris, Health Policy Actuary at Discovery Health, discusses South Africa's National Health Insurance, its potential, the reforms and changes, and the roles of the public and private sectors.بقلم IQVIA

1
Personalization Science: Episode 2 | The Evolution of Media Optimization Pt. 1 19:08

8M ago19:08

19:08

Welcome back to IQVIA Digital Enablement’s podcast series: Personalization Science. This week, we are joined by Jason Patterson, Chief Analytics Officer at Publicis Health Media, a top healthcare media agency built for the modern marketplace. In part 1 of this conversation, host Andrew Burkus and Jason dive into the world of healthcare media optimi…

1
What is the Role of Digital Pathology in Clinical Trials 29:00

11M ago29:00

29:00

In this episode, Dr. Monika Lamba, a pathologist from Q² Solutions, discusses the transformative role of digital pathology in clinical trials. Despite its origins aiming to streamline trials, it's not yet the default. Dr. Lamba explores its evolution from telepathology and its integration into trials. The conversation covers challenges in trial org…

1
AI in Pathology: Advancements, Challenges, and the Road Ahead 28:41

1+ y ago28:41

28:41

In this episode Dr. Monika Lamba Saini and Bruno Larvol of “LARVOL & Friends” discuss the role of artificial intelligence (AI) in pathology and its potential impact on healthcare. They delve into the slower adoption of AI in pathology compared to other medical specialties and examine the challenges that lie ahead. The conversation explores the need…

1
Flow Cytometry as an IVD technology for Companion Diagnostics 20:35

2y ago20:35

20:35

In this episode, Megan McCausland, Scientific Advisor for Flow Cytometry at Q2 Solutions, and Scott Bornheimer, Associate Director of Medical and Scientific Affairs at BD Biosciences talk about the enormous potential of flow cytometry as a clinical diagnostic tool. Currently, pharma companies are looking for simplified, standardized flow cytometry …

1
Flexible Approaches for Biotech Companies in Clinical Trials 23:21

2+ y ago23:21

23:21

With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech companies in clinical trials are different from larger sponsors. In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Mona Henderson, Director of Laboratory Network Sol…

1
Risk Management for Biotech Companies in Clinical Trials 21:15

2+ y ago21:15

21:15

In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies. Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a n…

1
3 Things to Consider in Preparation for Your Biotech Testing or Trial 25:06

2+ y ago25:06

25:06

Alex Watt is the Global Head for Biotech Integrated Laboratory Solutions at Q2 Solutions. In this episode, the first of a three-part series, he talks about how biotech companies can best prepare for testing with a CRO or clinical trial. First it's important to understand you analytical needs. What services are needed to operationalize the study des…

1
Hybrid assays: an interview with Barry Jones and Adriane Spytko 11:14

2+ y ago11:14

11:14

Becoming bilingual in bioanalysis In this podcast Barry Jones (Director, LC–MS Biologics and Biomarkers at Q² Solutions) and Adriane Spytko (Manager, LC–MS Biologics at Q² Solutions; both NY, USA) discuss hybrid assays using both LBA and LC−MS techniques. They share their thoughts on bottom-up LC−MS methods and the concern about detecting analyte t…

1
Managing Sample Data from Vendors 17:33

3y ago17:33

17:33

Most clinical trials involve a variety of laboratory vendors and CROs to provide services during the course of the study. Disparity in how each vendor handles, tracks and reports its data can present a challenge. In this episode, Barbara Nagaraj, Senior IT Architect at Biofortis, a Q2 Solutions company, describes those challenges and how to mitigat…

1
Automation within an ADME Laboratory 8:15

3y ago8:15

8:15

Taking an assay from bench to an automated platform In this podcast, Prakash Bhosale (Director of Discovery ADME at Q2 Solutions; IN, USA) discusses high-throughput in vitro screening and how to understand structure-activity relationships against ADME properties. The advantages of the Tecan technology are also addressed as well as top tips for driv…

1
Bioanalytical Automation of Samples 11:18

3y ago11:18

11:18

In this podcast interview, Jason Evans (Scientist at Q² Solutions) discusses the importance of automation and key advantages of taking an assay from the bench to an automated platform. He also explains the increase in throughput when his lab transitioned to automated assays and the hurdles he faced when automating assays.…

1
Consent Tracking for Clinical Samples 18:12

3y ago18:12

18:12

Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use. In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as…

1
Tracking Clinical Trial Samples 14:23

3y ago14:23

14:23

The clinical trial ecosystem is a complex web of investigator sites, laboratories, couriers, patient samples and more. The ability to track those samples though this ecosystem with full visibility for the sponsor is essential for a successful trial. In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, describes t…

1
Avoiding Canceled Tests in Pediatric Samples 19:59

3+ y ago19:59

19:59

In this episode, Charlie Fix, Global Director of Scientific Harmonization for Q Squared Solutions describes the challenges of safety testing for drugs in pediatric patients where sample volumes may be limited. Clinical analyzers are set up to maximize throughput and minimize turnaround time. When a panel of multiple tests is ordered and a sample do…

1
Covid Vaccine Testing 18:56

4y ago18:56

18:56

In this episode, Dr. Robert Bailer, Senior Director for Vaccines at Q2 Solutions, describes the processes for testing vaccines against the novel coronavirus, SARS-CoV-2. He covers both ELISA and virus neutralization assays. Q2 Solutions has developed an ELISA assay to evaluate multiple different antigens at the same time. Looking primarily at the s…

1
Hybrid Assays for Protein Bioanalysis 24:21

4y ago24:21

24:21

In this episode, Drs. Steven Lowes and Barry Jones discuss hybrid assays, combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS). This is a growing area of opportunity for protein bioanalysis. Topics covered include: What is meant by hybrid assay Reasons to choose a hybrid assay Top down vs bottom up Specific challenges Assa…

1
High Throughput ADME Testing 20:33

4y ago20:33

20:33

ADME testing (Absorption, Distribution, Metabolism and Excretion) is an essential part of early stage drug development. In this episode, Dr. Matt Hutzler, Director of ADME Services at Q2 Solutions, describes the common paradigm of ADME testing and why short turnaround times are important. Because speed is so important, outsourcing testing overseas …

1
Liquid Biopsy Collection in Clinical Development Programs 22:37

4y ago22:37

22:37

A liquid biopsy is a minimally invasive alternative to a more traditional surgical solid tumor biopsy. In this episode, Dr. Stephanie Hastings, genomics product lead at Q Squared Solutions, lays out the considerations for liquid biopsy collection and the type of information that can be gathered from circulating free DNA (cfDNA). The main approaches…

1
An Next Generation Sequencing Approach to Influenza Vaccine Development 24:00

5y ago24:00

24:00

In this episode, Dr. Wayne Hogrefe and Dr. Pat Hurban discuss the use of NGS in the development and assessment of new vaccines against the influenza virus. Topics covered include: What health organizations are looking for that drives the selection of the next season's vaccine strains How sequence data is used to evaluate the effectiveness of a vacc…

1
Standardization of Tumor Mutational Burden by Alignment to Reference Standards 28:22

5y ago28:22

28:22

In this episode, Victor Weigman, Director of Translational Genomics at Q Squared Solutions and Mark Stewart, Vice President of Science Policy at Friends of Cancer Research (FOCR) joined to talk about standardization of TMB measurements by alignment to reference standards. TMB differs from other biomarkers such as PDL1 in that: "...we're leveraging …

1
Monitoring the Tumor Micro-environment with Flow Cytometry - Mark Edinger 20:22

5+ y ago20:22

20:22

Mark Edinger is the Scientific Advisor for Flow Cytometry at Q2 Solutions. In this episode, he describes recent advances in flow cytometry and what that means for immuno-oncology trials. New instruments, reagents and software are enabling researchers to monitor 30-some markers simultaneously to get a better picture of the tumor micro-environment an…

المدونة الصوتية تستحق الاستماع

Iqvia بودكاست

المدونة الصوتية تستحق الاستماع

دليل مرجعي سريع